Alx Oncology Holdings (ALXO) Other Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Other Non-Current Liabilities data on file, last reported at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 37.7% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 37.7% YoY), and the FY2025 full-year result was $4.0 million, down 35.68% from the prior year.
• Other Non-Current Liabilities eased to $3.5 million in Q1 2026, from $4.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $7.2 million in Q4 2023 to a low of $3.5 million in Q1 2026.
• A 5-year average of $5.7 million and a median of $5.7 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities jumped 1506.73% in 2022 and tumbled 37.7% in 2026, its largest moves.
• Tracing ALXO's Other Non-Current Liabilities over 5 years: stood at $5.3 million in 2022, then soared by 35.59% to $7.2 million in 2023, then dropped by 14.07% to $6.2 million in 2024, then plunged by 35.68% to $4.0 million in 2025, then slipped by 11.86% to $3.5 million in 2026.
• Business Quant data shows ALXO's Other Non-Current Liabilities at $3.5 million in Q1 2026, $4.0 million in Q4 2025, and $4.4 million in Q3 2025.